REQUEST A DEMO
press releases | MobileODT

MobileODT completed $4 million series round C

The round will support the development of AI cervical cancer screening device MobileODT, the developer of the EVA System for cervical cancer screening, announced the completion of a $4 million series C fundraising round. The round will enable MobileODT to further...

MobileODT completes second institutional financing

MobileODT is pleased to announce it has successfully completed its second round of institutional financing. The announcement comes shortly before the launch of its AI-based cervical cancer screening test, VisualPap. OrbiMed Israel Advisors led the round, with Tara...

MobileODT Secures Series B Funding led by OrbiMed

Today, MobileODT announced it has raised an additional $6.825 million in a Series B fundraising round led by OrbiMed Advisors - a leading healthcare venture fund. Previous investors Tristel plc. also participated in the round. MobileODT has raised over $13 million to...

New Mobile Colposcope Outshining Standard

(June 12, 2017) Today, MobileODT announced the launch of its third generation mobile colposcope, the FDA-cleared EVA System. This improved device is 12% lighter, boasts improved lighting, and expands the user’s network and support system by serving as a secure...

Pin It on Pinterest